Life Should Be Disease Less – Oncotarget Knows How to Achieve This

Established in 2010, Oncotarget is a weekly peer review medical journal that focuses and publishes researches that deal with oncology. The word Oncotarget includes all molecules, passageways and cellular functions in cancer and aging. It also includes neurodegeneration and atherosclerosis, Cancerous cells and microbes, and the neurons and lymphocytes.

Impact journals are in charge of publishing all the reviews on Oncotarget. This traditional multidisciplinary journal offers free access to anyone interested in reading their articles and research.

It is close to people’s hearts for it encourages writers and researchers who have had their articles rejected by other leading journals to submit those reports to them. However, they should submit them alongside the peer–reviews gathered from the said journals and rebuttal letters.

Oncotarget primary objective is to have scientific results surrounding oncology widely available. Every day, they try to maximize the impact of any research through incisive review. This way, outstanding discoveries are shared vastly and quickly.

Currently, there are still borders between specialties, but this is what Oncotarget is working to eliminate. Other Oncotarget missions include linking different biomedical science fields and also fostering the application of basic and clinical science to fight diseases

Dove Press revealed that at Oncotarget, we believe that life should be free of diseases and that is why we continue to give researchers a platform to contribute to the advancement of science. This can always be a reality since Oncotarget is under the leadership of outstanding scientists. Lately, the journal has launched sections beyond just oncology. This counts as another of our successes.

At the brim of this weekly journal are its two editors-in-chief, Mikhail Blagosklonny and Andrei V. Gudkov. Being a Roswell Park of cancer institute professor of cancer, Mikhail Blagosklonny is a renowned scientist that studies cancer and aging.

He attended First Pavlov State Medical University of St. Peterburg and earned his M.D. in internal medicine and also a Ph.D. in experimental medicine and cardiology.

On the other hand, Andrei V. Gudkov was a Senior Vice President of Basic Science, the chair of Department of Cell Stress Biology, and a senior leadership team member for National Cancer Institute (NCI). At Roswell Park Cancer Institute since 2007, he worked at the Cancer Center Support Grant. He is interested in drug recovery approaches, cancer treatment molecular targets and gene discovery.

Comments are closed, but trackbacks and pingbacks are open.